What's New

  • From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care

    From every angle: Dr. Von Nguyen brings rare background to quest for high-value specialty care

    Chief Clinical Officer Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to Evolent.

    Read Article
  • Repairing Fragmented Care with Value-Based Strategies

    Repairing Fragmented Care with Value-Based Strategies

    Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth.

    Listen to Podcast
  • Let's Go
  • Why health plans need to refresh their surgical implant strategy

    Why health plans need to refresh their surgical implant strategy

    Barriers related to implantable devices often keep orthopedic procedures from being peformed outside the hospital.

    Read Article
  • AI-curated clinical pathways? Not so fast.

    AI-curated clinical pathways? Not so fast.

    Could generative AI replace expert consensus for devising clinical guidelines? Our chief medical officer takes a look.

    Read Article
  • Value-based strategies for connecting primary and specialty care

    Value-based strategies for connecting primary and specialty care

    To reduce the fragmentation of care for complex conditions, we need to take on the fee-for-service models that contribute to it, says Evolent’s Dr. Vishnukamal Golla.

    Read Article
  • Another Toxicity of Cancer Treatment

    Another Toxicity of Cancer Treatment

    Cancer treatment and the time spent traveling for care are often very time-consuming. By recognizing and working to decrease time toxicity for patients with cancer, we can lessen their burden.

    Read Article
  • Visit Website
  • Dr. Sadie Dobrozsi Discusses the Future of Genetic Testing in Oncology and the Impact on Women’s Health

    Dr. Sadie Dobrozsi Discusses the Future of Genetic Testing in Oncology and the Impact on Women’s Health

    A stronger, unified voice in our scientific community will impact the accessibility of genetic testing so that it becomes standard preventive care for everyone who qualifies — and who wants it.

    Read Article
  • Evolent to acquire AI utilization management products and team from Machinify

    Evolent to acquire AI utilization management products and team from Machinify

    Addition will help Evolent to increase first-pass approvals and streamline data collection in complex medical decision making.

    Read Press Release
  • Evolent and Careology form strategic care navigation partnership

    Evolent and Careology form strategic care navigation partnership

    Joint offering will seek to to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.

    Read Press Release
  • True peer-to-peer conversations will improve prior authorization

    True peer-to-peer conversations will improve prior authorization

    Dr. Matthew Walker writes in STAT about one big step to make peer conversations more collegial and productive.

    Read External Article
  • The “dystopian” state of primary care 10:51

    The “dystopian” state of primary care

    Evolent's Dr. Kamal Golla speaks with the Healthcare Finance Management Association’s Voices podcast about the challenges of connecting primary and specialty care.

    Listen to Podcast
  • Clinical Expertise When It Matters Most2:03

    Clinical Expertise When It Matters Most

    Our evidence-driven, patient-first model helps produce more informed decisions.

    Watch Video
  • Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

    Evolent Announces Focus on Specialty Care With Rebrand, Unification of Solutions

    Company's solutions are coming together to improve outcomes for people living with complex health conditions.

    Read Press Release
  • It's Cancer Prevention Month. Here are 11 ways to reduce your risk.

    It's Cancer Prevention Month. Here are 11 ways to reduce your risk.

    Our CMO, Dr. Andrew Hertler, talks to Yahoo Life about identifying which patients need genetic testing or aggressive cancer screening, the issues surrounding prophylactic surgery, and more.

    Read External Article
  • Trends clinical leaders, hospital execs say will shape healthcare beyond 2024

    Trends clinical leaders, hospital execs say will shape healthcare beyond 2024

    Becker's highlights our CMO's predictions on the future of health care.

    Read External Article
  • Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

    Prophylactic Mastectomy for Patients With High-Risk Gene Mutations

    Dr. Andrew Hertler discussed the importance of prophylactic mastectomy for individuals carrying BRCA1, BRCA2 and other deleterious mutations.

    Watch Video
  • Medicare Drug Price Negotiations and Anticipated Ripple Effects

    Medicare Drug Price Negotiations and Anticipated Ripple Effects

    Our vice president of pharmacy explores the hard-to-predict impacts of drug price negotiations on consumers, plans and pharmaceutical companies.

    Read External Article
  • Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

    Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care

    Our CMO speaks with Urban Health Today about who should get screened, the role of primary care physicians in identifying at-risk individuals, and more.

    Read External Article
  • Genetic Testing in Cancer Care: Considerations for a Condition-Based Approach

    Genetic Testing in Cancer Care: Considerations for a Condition-Based Approach

    Two Evolent experts discuss the benefits of genetic testing in oncology in American Journal of Managed Care.

    Read External Article
  • Evolent facilitates response to cancer drug shortages

    Evolent facilitates response to cancer drug shortages

    Evolent takes a multifaceted approach to help providers navigate shortages of cisplatin, carboplatin and other anti-cancer drugs.

    Read Article
  • loading
    Loading More...